Home  |   Technologies   |     Services    |    Careers    |    Contact

BioFluidica Microtechnologies LLC is developing exciting new point-of-care bioanalytical instrumentation for medical diagnostics (circulating tumor cells (CTC’s)), pathogen detection, and other fields where the detection and isolation of rare cells is critical.  The company will later develop the capabilities for integrated molecular verification of isolated CTC's.

The technology has already been demonstrated to efficiently detect breast and prostate CTC's from whole blood as well as rare bacterial species from water with high efficiency and specificity. From a medical perspective, the device provides simple blood-based testing for monitoring the efficacy of therapeutic intervention as well as the recurrence of many cancer-related diseases.  

The instrument uses a low-cost single-use plastic cartridge that can rapidly process large volumes (~10 ml) and efficiently (>90%) capture targeted low concentration (rare) cells (<1/ml) from any type of clinical or environmental liquid sample.  The highly integrated device can then release captured cells and count them (one cell at a time) with an on-board conductivity sensor. The single use, test-specific cartridge is produced by simple molding of a low-cost plastic material.   

Requisite technologies for this instrumentation were developed at Louisiana State University (LSU) under the direction of Prof. Steven A. Soper, renowned in the field with nearly 20 years of experience in bioanalytical research.

 

Still Under Construction

Please Come Back and Visit Us Later!

For more information, send email to info@biofluidica.com.

Copyright BioFluidica Microtechnologies LLC 2010

Sign in  |  Recent Site Activity  |  Terms  |  Report Abuse  |  Print page  |  Powered by Google Sites